April 16, 2015 | Sun Pharmaceutical Industries and the Technion Israel Institute of Technology announced that they have entered into a worldwide research and licence agreement. The agreement is aimed at the development of a joint project, based on findings made by Nobel Prize laureate Aaron Ciechanover, that could potentially lead to the development of anti-cancer drugs.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments